These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 7427948

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer.
    Kurebayashi J, Ishida T, Higashi Y, Suemasu K, Nomoto C, Yoshida K.
    Jpn J Clin Oncol; 1990 Sep; 20(3):271-80. PubMed ID: 2255103
    [Abstract] [Full Text] [Related]

  • 3. [Hormone receptors and breast cancer prognosis].
    Saez S, Pichon MF.
    Pathol Biol (Paris); 1983 Dec; 31(10):801-8. PubMed ID: 6366701
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunocytochemical determination of estrogen receptor, progesterone receptor, and 1,25-dihydroxyvitamin D3 receptor in breast cancer and relationship to prognosis.
    Berger U, McClelland RA, Wilson P, Greene GL, Haussler MR, Pike JW, Colston K, Easton D, Coombes RC.
    Cancer Res; 1991 Jan 01; 51(1):239-44. PubMed ID: 1846309
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J, Danish Breast Cancer Cooperative Group.
    J Clin Oncol; 2008 Mar 20; 26(9):1419-26. PubMed ID: 18285604
    [Abstract] [Full Text] [Related]

  • 8. Steroid hormone receptors in the management of human breast cancer.
    Knight WA, Osborne CK, Yochmowitz MG, McGuire WL.
    Ann Clin Res; 1980 Oct 20; 12(5):202-7. PubMed ID: 7015982
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Improved measurement of androgen receptors in human breast cancer.
    Lea OA, Kvinnsland S, Thorsen T.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7162-7. PubMed ID: 2582456
    [Abstract] [Full Text] [Related]

  • 12. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R, Farrus B, Filella X, Jo J, Zanón G, Pahisa J, Latre M, Muñoz M, Ballesta AM.
    Anticancer Res; 1999 Dec 15; 19(4A):2557-62. PubMed ID: 10470194
    [Abstract] [Full Text] [Related]

  • 13. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA.
    Anticancer Res; 2004 Dec 15; 24(4):2391-400. PubMed ID: 15330189
    [Abstract] [Full Text] [Related]

  • 14. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
    Fehm T, Maul H, Gebauer S, Scharf A, Baier P, Sohn C, Jäger W, Gebauer G.
    Strahlenther Onkol; 2005 Sep 15; 181(9):580-6. PubMed ID: 16170485
    [Abstract] [Full Text] [Related]

  • 15. Estrogen receptor-negative, progesterone receptor-positive breast carcinoma: poor clinical outcome.
    Keshgegian AA, Cnaan A.
    Arch Pathol Lab Med; 1996 Oct 15; 120(10):970-3. PubMed ID: 12046611
    [Abstract] [Full Text] [Related]

  • 16. Elastosis in human breast cancer. Correlation with sex steroid receptors and comparison with clinical outcome.
    Glaubitz LC, Bowen JH, Cox EB, McCarty KS.
    Arch Pathol Lab Med; 1984 Jan 15; 108(1):27-30. PubMed ID: 6546333
    [Abstract] [Full Text] [Related]

  • 17. Inverse correlation between the expression of O6-methylguanine-DNA methyl transferase (MGMT) and p53 in breast cancer.
    Osanai T, Takagi Y, Toriya Y, Nakagawa T, Aruga T, Iida S, Uetake H, Sugihara K.
    Jpn J Clin Oncol; 2005 Mar 15; 35(3):121-5. PubMed ID: 15741301
    [Abstract] [Full Text] [Related]

  • 18. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
    Janssen EA, Baak JP, Guervós MA, van Diest PJ, Jiwa M, Hermsen MA.
    J Pathol; 2003 Dec 15; 201(4):555-61. PubMed ID: 14648658
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
    Bartlett JM, Ellis IO, Dowsett M, Mallon EA, Cameron DA, Johnston S, Hall E, A'Hern R, Peckitt C, Bliss JM, Johnson L, Barrett-Lee P, Ellis P.
    J Clin Oncol; 2007 Oct 01; 25(28):4423-30. PubMed ID: 17906205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.